2024

Gonçalves A, Marchand M, Chan P, Jin JY, Guedj J, Bruno R
Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancer.
CPT: pharmacometrics & systems pharmacology 2024, 13, 68-78.

2023

El Messaoudi S, Lemenuel-Diot A, Gonçalves A, Guedj J
A Semi-mechanistic Model to Characterize the Long-Term Dynamics of Hepatitis B Virus Markers During Treatment With Lamivudine and Pegylated Interferon.
Clinical Pharmacology and Therapeutics 2023, 113, 390-400.

2022

El Messaoudi S, Lemenuel-Diot A, Gonçalves A, Guedj J
A semi-mechanistic model to characterize the long-term dynamic of HBV markers during treatment with lamivudine and Peg-IFN.
Clinical Pharmacology & Therapeutics 2022

2021

Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina NA, Freyn AW, Snitselaar JL, Gonçalves A, Caniels TG, Burger JA, Poniman M, Bontjer I, Chesnais V, Diry S, Iershov A, Ronk AJ, Jangra S, Rathnasinghe R, Brouwer PJM, Bijl TPL, van Schooten J, Brinkkemper M, Liu H, Yuan M, Mire CE, van Breemen MJ, Contreras V, Naninck T, Lemaître J, Kahlaoui N, Relouzat F, Chapon C, Ho Tsong Fang R, McDanal C, Osei-Twum M, St-Amant N, Gagnon L, Montefiori DC, Wilson IA, Ginoux E, de Bree GJ, García-Sastre A, Schotsaert M, Coughlan L, Bukreyev A, van der Werf S, Guedj J, Sanders RW, van Gils MJ, Le Grand R
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Nature Communications 2021, 12, 6097.

Gonçalves A, Lemenuel-Diot A, Cosson V, Jin Y, Feng S, Bo Q, Guedj J
What drives the dynamics of HBV RNA during treatment?.
Journal of Viral Hepatitis 2021, 28, 383-392.

Czuppon P, Débarre F, Gonçalves A, Tenaillon O, Perelson AS, Guedj J, Blanquart F
Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.
PLoS computational biology 2021, 17, e1008752.

Gonçalves A, Maisonnasse P, Donati F, Albert M, Behillil S, Contreras V, Naninck T, Marlin R, Solas C, Pizzorno A, Lemaitre J, Kahlaoui N, Terrier O, Ho Tsong Fang R, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Rosa Calatrava M, de Lamballerie X, Mentré F, Le Grand R, van der Werf S, Guedj J
SARS-CoV-2 viral dynamics in non-human primates.
PLoS computational biology 2021, 17, e1008785.

2020

Gonçalves A, Bertrand J, Ke R, Comets E, de Lamballerie X, Malvy D, Pizzorno A, Terrier O, Rosa Calatrava M, Mentré F, Smith P, Perelson AS, Guedj J
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.
CPT: pharmacometrics & systems pharmacology 2020, 9, 509-514.

Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, Naninck T, Pizzorno A, Lemaitre J, Gonçalves A, Kahlaoui N, Terrier O, Fang RHT, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Calatrava MR, van der Werf S, de Lamballerie X, Le Grand R
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Nature 2020, 585, 584-587.

Gonçalves A, Mentré F, Lemenuel-Diot A, Guedj J
Model Averaging in Viral Dynamic Models.
The AAPS journal 2020, 22, 48.

2017

Dantas NGT, Suffys PN, Carvalho WdS, Gomes HM, Almeida INd, Figueiredo LJdA, Gonçalves AD, Gomgnimbou MK, Refregier G, Sola C, Miranda SSd
Correlation between the BACTEC MGIT 960 culture system with Genotype MTBDRplus and TB-SPRINT in multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil..
Memorias do Instituto Oswaldo Cruz 2017, 112, 769-774.

2011

Radomski N, Betelli L, Moilleron R, Haenn S, Moulin L, Cambau E, Rocher V, Gonçalves A, Lucas FS
Mycobacterium behavior in wastewater treatment plant, a bacterial model distinct from Escherichia coli and Enterococci..
Environmental science & technology 2011, 45, 5380-5386.